If there’s one thing you learn about successful investing it’s that picking the right stocks is not the most important part of it all. This may seem a bit strange coming from me. As the editor of the Oakes Momentum Report, I’ve spent over a decade refining a system to pick winning stocks. But picking…
DetailsDear Profit Alert reader, I would love nothing more than to talk more about the coming data explosion today. It’s going to be right up there with cloud computing, smartphones, and all the other major tech trends. All of which have made fortunes for investors who jumped on and rode them to the top. Also,…
DetailsAbout a year and a half ago I got cable TV for the first time in over a decade. There was only one reason. NBC Sports inked a deal to broadcast English Premier League soccer games and invested heavily in production to make the quality just as good as watching from a pub in Newcastle.…
DetailsThe next phase of the Greek crisis here…I’m hope it gets worse. Earlier this morning the main page of Yahoo Finance said, “World markets are plunging as Greek voters say ‘no’ to new austerity measures.” They’re right in that while Americans were out buying discount mattresses and attending “Tent Events” and Toyotathons, Greek voters went…
DetailsA few years ago the Profit Alert said we’re entering a “Golden Age” for biotech. There were just so many driving forces… There was the “patent cliff” forcing top pharmaceutical companies to acquire new drugs. There were technological developments in a number of fields like genomics. And there was the hundreds of billions of dollars…
Details“Valuation metrics in some sectors do appear substantially stretched—particularly those for smaller firms in the social media and biotechnology industries.” That’s what Janet Yellen, the head of the Federal Reserve, stated 11 months ago. The warning couldn’t have been more wrong. Since then the Nasdaq Biotechnology Index rose 54%. Now, that’s an extreme gain for…
DetailsEvery year in late May 30,000 oncology professionals from around the world gather in one place – the world’s largest oncology conference – to discuss the latest groundbreaking cancer research. You won’t ever see this much knowledge, experience and exposure of the most groundbreaking cancer research in the same place anywhere else in the world.…
DetailsNow is the time to create or add to your positions in the biotech sector? But you have to be strategic about it. And why now? Every year in late May 30,000 oncology professionals gather in one place – the world’s largest oncology conference – to discuss groundbreaking cancer research and which companies in the…
DetailsYou’ve seen this situation before and you know how lucrative it can be. A country has been through years of economic malaise. Stocks are way down from past highs. The country’s central bank, fearful of continued anemic growth, commits to a massive stimulus program. Despite the flaws of the policy, stocks start going up. They…
DetailsThis stock has had an amazing run over the last 15 years. It’s soared from $3 to $68. And the next 15 years are probably going to be ever better for it. I’ve got to tell you though, the shares of the company are probably not any sexy industry where huge returns are common among…
DetailsThis has only happened twice the last six years. Each time was a disaster for most investors. Yet it created a wildly profitable for investors who saw it coming. Here’s what it is and how to make sure you’re one of the few who benefits from it. The Last Time This Happened Stocks Dropped 20%…
DetailsIt’s Memorial Day and the markets are closed. So we want to be brief. But we also take ake advantage of a holiday like today. On market holidays there’s no media noise. There aren’t many earnings announcements or economic news. There aren’t any short-term terms moves in prices that will inevitably extrapolated indefinitely into the…
Details